Re: Separation Agreement Dear Martin:Letter Agreement • November 14th, 2023 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations
The purpose of this letter agreement (this “Agreement”) is to set forth the terms of your transition and separation from Bellerophon Therapeutics, Inc. (the “Company”).
